10-K Filing

LifeMD, Inc. CIK: 948320 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001493152-23-008560`
Period End Date	20221231
Filing Date	20230322
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 50 Cash Flow Statement 118 Stockholders Equity 32

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$3.96M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$41.33M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$2.83M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$980.05K	USD	Point-in-time
Product deposit	`DepositsAssetsCurrent`	$127.27K	USD	Point-in-time
Product deposit	`DepositsAssetsCurrent`	$203.56K	USD	Point-in-time
Inventory, net	`InventoryNet`	$1.62M	USD	Point-in-time
Inventory, net	`InventoryNet`	$3.70M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$687.02K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$793.19K	USD	Point-in-time
Temporary equity, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Temporary equity, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Temporary equity, shares authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$44.92M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$11.31M	USD	Point-in-time
Temporary equity, shares authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$233.81K	USD	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$476.44K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$1.21M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$1.75M	USD	Point-in-time
Capitalized software, net	`CapitalizedComputerSoftwareNet`	$3.00M	USD	Point-in-time
Capitalized software, net	`CapitalizedComputerSoftwareNet`	$8.84M	USD	Point-in-time
Series A Preferred Stock, at par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$19.76K	USD	Point-in-time
Series A Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$3.83M	USD	Point-in-time
Total Non-current Assets	`AssetsNoncurrent`	$5.00M	USD	Point-in-time
Total Non-current Assets	`AssetsNoncurrent`	$14.35M	USD	Point-in-time
Total Assets	`Assets`	$25.67M	USD	Point-in-time
Total Assets	`Assets`	$49.92M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.11M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$9.06M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.55M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.70M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$11.60M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.17M	USD	Point-in-time
Notes payable, net	`NotesPayableCurrent`	$63.40K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.60M	shares	Point-in-time
Notes payable, net	`NotesPayableCurrent`	$2.80M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.45M	shares	Point-in-time
Current operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$607.49K	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	103,040.00	shares	Point-in-time
Current operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$756.09K	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	103,040.00	shares	Point-in-time
Deferred revenue	`DeferredRevenue`	$1.50M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$5.55M	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$916.88K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$31.37M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$22.83M	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$574.14K	USD	Point-in-time
Noncurrent operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.18M	USD	Point-in-time
Contingent consideration	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$100.00K	USD	Point-in-time
Contingent consideration	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$443.75K	USD	Point-in-time
Purchase price payable	`PurchasePricePayable`	$579.32K	USD	Point-in-time
Purchase price payable	`PurchasePricePayable`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$24.10M	USD	Point-in-time
Total Liabilities	`Liabilities`	$32.97M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, 3,500 and 3,500 shares issued and outstanding, liquidation value approximately, $1,305 and $1,175 per share as of December 31, 2022 and 2021, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$4.11M	USD	Point-in-time
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, 3,500 and 3,500 shares issued and outstanding, liquidation value approximately, $1,305 and $1,175 per share as of December 31, 2022 and 2021, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$4.57M	USD	Point-in-time
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 and 1,400,000 shares issued and outstanding, liquidation value approximately, $27.84 and $25.62 per share as of December 31, 2022 and 2021, respectively	`PreferredStockValue`	$140.00	USD	Point-in-time
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 and 1,400,000 shares issued and outstanding, liquidation value approximately, $27.84 and $25.62 per share as of December 31, 2022 and 2021, respectively	`PreferredStockValue`	$140.00	USD	Point-in-time
Common Stock, $0.01 par value; 100,000,000 shares authorized, 31,552,775 and 30,704,434 shares issued, 31,449,735 and 30,601,394 outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$307.05K	USD	Point-in-time
Common Stock, $0.01 par value; 100,000,000 shares authorized, 31,552,775 and 30,704,434 shares issued, 31,449,735 and 30,601,394 outstanding as of December 31, 2022 and 2021, respectively	`CommonStockValue`	$315.53K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$179.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$164.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-141.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-190.56M	USD	Point-in-time
Treasury stock, 103,040 and 103,040 shares, at cost, as of December 31, 2022 and 2021, respectively	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Treasury stock, 103,040 and 103,040 shares, at cost, as of December 31, 2022 and 2021, respectively	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Total LifeMD, Inc. Stockholders (Deficit) Equity	`StockholdersEquity`	$22.74M	USD	Point-in-time
Total LifeMD, Inc. Stockholders (Deficit) Equity	`StockholdersEquity`	$-11.40M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-1.03M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-475.55K	USD	Point-in-time
Total Stockholders (Deficit) Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$21.71M	USD	Point-in-time
Total Stockholders (Deficit) Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.48M	USD	Point-in-time
Total Stockholders (Deficit) Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-11.87M	USD	Point-in-time
Total Liabilities, Mezzanine Equity and Stockholders (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$49.92M	USD	Point-in-time
Total Liabilities, Mezzanine Equity and Stockholders (Deficit) Equity	`LiabilitiesAndStockholdersEquity`	$25.67M	USD	Point-in-time

Income Statement 50 line items

Line Item	Tag	Value	Unit	Period
Total revenues, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$119.03M	USD	Annual
Total revenues, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$92.88M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$18.67M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$18.00M	USD	Annual
Gross profit	`GrossProfit`	$74.88M	USD	Annual
Gross profit	`GrossProfit`	$100.37M	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$78.37M	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$82.54M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$46.96M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$39.53M	USD	Annual
Goodwill and intangible asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	$8.86M	USD	Annual
Goodwill and intangible asset impairment charges	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Other operating expenses	`OtherGeneralExpense`	$3.32M	USD	Annual
Other operating expenses	`OtherGeneralExpense`	$6.72M	USD	Annual
Customer service expenses	`OtherSellingGeneralAndAdministrativeExpense`	$5.03M	USD	Annual
Customer service expenses	`OtherSellingGeneralAndAdministrativeExpense`	$2.84M	USD	Annual
Development costs	`DevelopmentCosts`	$948.16K	USD	Annual
Development costs	`DevelopmentCosts`	$2.97M	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$5.10M	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	-	USD	Annual
Total expenses	`OperatingExpenses`	$129.18M	USD	Annual
Total expenses	`OperatingExpenses`	$143.81M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-43.45M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-54.30M	USD	Annual
Interest expense, net	`InterestExpense`	$1.28M	USD	Annual
Interest expense, net	`InterestExpense`	$3.02M	USD	Annual
Gain (loss) on debt forgiveness	`GainLossOnDebtForgiveness`	$63.40K	USD	Annual
Gain (loss) on debt forgiveness	`GainLossOnDebtForgiveness`	$-4.00M	USD	Annual
Loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.66M	USD	Annual
Loss from operations before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-61.32M	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$7.70K	USD	Annual
Income tax provision	`IncomeTaxExpenseBenefit`	$360.70K	USD	Annual
Net loss	`ProfitLoss`	$-61.32M	USD	Annual
Net loss	`ProfitLoss`	$-45.02M	USD	Annual
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$514.63K	USD	Annual
Net income (loss) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-426.35K	USD	Annual
Net loss attributable to LifeMD, Inc.	`NetIncomeLoss`	$-60.90M	USD	Annual
Net loss attributable to LifeMD, Inc.	`NetIncomeLoss`	$-45.54M	USD	Annual
Preferred stock dividends	`PreferredStockDividendsIncomeStatementImpact`	$871.48K	USD	Annual
Preferred stock dividends	`PreferredStockDividendsIncomeStatementImpact`	$3.11M	USD	Annual
Net loss attributable to LifeMD, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-48.64M	USD	Annual
Net loss attributable to LifeMD, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-61.77M	USD	Annual
Basic loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.57	USD	Annual
Basic loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.29	USD	Annual
Diluted loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.57	USD	Annual
Diluted loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.29	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	27.01M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	30.98M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.01M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.98M	shares	Annual

Cash Flow Statement 118 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-61.32M	USD	Annual
Net loss	`ProfitLoss`	$-45.02M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$2.09M	USD	Annual
Amortization of capitalized software	`CapitalizedComputerSoftwareAmortization1`	$512.89K	USD	Annual
Amortization of capitalized software	`CapitalizedComputerSoftwareAmortization1`	$2.68M	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$342.31K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$926.54K	USD	Annual
Accretion of consideration payable	`AccretionExpenseIncludingAssetRetirementObligations`	-	USD	Annual
Accretion of consideration payable	`AccretionExpenseIncludingAssetRetirementObligations`	$273.82K	USD	Annual
Depreciation of fixed assets	`Depreciation`	$161.88K	USD	Annual
Depreciation of fixed assets	`Depreciation`	$13.56K	USD	Annual
Write-down of inventory	`InventoryWriteDown`	$103.42K	USD	Annual
Write-down of inventory	`InventoryWriteDown`	$57.48K	USD	Annual
Sales returns reserve	`SalesReturnsReserve`	$338.19K	USD	Annual
Sales returns reserve	`SalesReturnsReserve`	-	USD	Annual
(Gain) loss on debt forgiveness	`GainLossOnDebtForgiveness`	$63.40K	USD	Annual
(Gain) loss on debt forgiveness	`GainLossOnDebtForgiveness`	$-4.00M	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	-	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$5.10M	USD	Annual
Goodwill and intangible asset impairment charges	`AssetImpairmentCharges`	$8.86M	USD	Annual
Goodwill and intangible asset impairment charges	`AssetImpairmentCharges`	-	USD	Annual
Deferred income tax provision	`DeferredIncomeTaxExpenseBenefit`	-	USD	Annual
Deferred income tax provision	`DeferredIncomeTaxExpenseBenefit`	$354.00K	USD	Annual
Operating lease payments	`OperatingLeasePaymentsAdjustments`	$22.70K	USD	Annual
Operating lease payments	`OperatingLeasePaymentsAdjustments`	$546.44K	USD	Annual
Stock issued for legal settlement	`StockIssuedForLegalSettlement`	-	USD	Annual
Stock issued for legal settlement	`StockIssuedForLegalSettlement`	$816.00K	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$12.07M	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$13.73M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.19M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-17.70K	USD	Annual
Product deposit	`IncreaseDecreaseInContractWithCustomerAsset`	$-76.29K	USD	Annual
Product deposit	`IncreaseDecreaseInContractWithCustomerAsset`	$-613.21K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$2.18M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$409.82K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-106.17K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$638.31K	USD	Annual
Change in operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	Annual
Change in operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-455.81K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$4.05M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$583.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-893.96K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.25M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.31M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$9.86M	USD	Annual
Other operating activity	`IncreaseDecreaseInOtherOperatingLiabilities`	-	USD	Annual
Other operating activity	`IncreaseDecreaseInOtherOperatingLiabilities`	$-888.49K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-33.09M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.94M	USD	Annual
Cash paid for capitalized software costs	`PaymentsToAcquireSoftware`	$3.13M	USD	Annual
Cash paid for capitalized software costs	`PaymentsToAcquireSoftware`	$8.53M	USD	Annual
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$366.63K	USD	Annual
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$247.37K	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$4.00M	USD	Annual
Purchase of intangible assets	`PaymentsToAcquireIntangibleAssets`	$22.23K	USD	Annual
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$460.00K	USD	Point-in-time
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisition of business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.01M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.40M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-13.91M	USD	Annual
Cash proceeds from private placement offering, net	`ProceedsFromIssuanceOfPrivatePlacement`	$60.00M	USD	Point-in-time
Cash proceeds from private placement offering, net	`ProceedsFromIssuanceOfPrivatePlacement`	$13.50M	USD	Annual
Cash proceeds from private placement offering, net	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	Annual
Proceeds from issuance of debt instruments	`ProceedsFromIssuanceOfDebt`	$15.00M	USD	Annual
Proceeds from issuance of debt instruments	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Cash proceeds from Series A Preferred and Common Stock Offering	`CashProceedsFromSeriesPreferredAndCommonStockOffering`	-	USD	Annual
Cash proceeds from Series A Preferred and Common Stock Offering	`CashProceedsFromSeriesPreferredAndCommonStockOffering`	$55.34M	USD	Annual
Repayment of debt instruments	`RepaymentsOfDebt`	$15.00M	USD	Annual
Repayment of debt instruments	`RepaymentsOfDebt`	-	USD	Annual
Cash proceeds from sale of common stock under ATM	`ProceedsFromIssuanceOfCommonStock`	$493.48K	USD	Annual
Cash proceeds from sale of common stock under ATM	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Cash proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$480.61K	USD	Annual
Cash proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$38.50K	USD	Annual
Cash proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$670.75K	USD	Annual
Cash proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$90.40K	USD	Annual
Preferred stock dividends	`PaymentsOfDividends`	$871.48K	USD	Annual
Preferred stock dividends	`PaymentsOfDividends`	$3.11M	USD	Annual
Purchase of membership interest of WorkSimpli	`PurchaseOfMembershipInterest`	-	USD	Annual
Purchase of membership interest of WorkSimpli	`PurchaseOfMembershipInterest`	$-300.00K	USD	Annual
Adjustment of membership interest in WorkSimpli	`AdjustmentOfMembershipInterest`	-	USD	Annual
Adjustment of membership interest in WorkSimpli	`AdjustmentOfMembershipInterest`	$12.15K	USD	Annual
Contingent consideration payment for ResumeBuild acquisition	`PaymentsToAcquireProductiveAsset`	-	USD	Annual
Contingent consideration payment for ResumeBuild acquisition	`PaymentsToAcquireProductiveAsset`	$156.25K	USD	Annual
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$144.00K	USD	Annual
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$144.00K	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$2.91M	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$963.97K	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$1.49M	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$168.75K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-528.20K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$68.64M	USD	Annual
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-37.37M	USD	Annual
Net (decrease) increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$32.15M	USD	Annual
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$41.33M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.96M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.18M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$41.33M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.96M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.18M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$435.05K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$189.00K	USD	Annual
Cashless exercise of options	`CashlessExerciseOfOptions`	$297.00	USD	Annual
Cashless exercise of options	`CashlessExerciseOfOptions`	$8.73K	USD	Annual
Consideration payable for Cleared acquisition	`ConsiderationPayableForClearedAcquisition`	$8.08M	USD	Annual
Consideration payable for Cleared acquisition	`ConsiderationPayableForClearedAcquisition`	-	USD	Annual
Consideration payable for ResumeBuild acquisition	`ConsiderationPayableForResumebuildAcquisition`	$500.00K	USD	Annual
Consideration payable for ResumeBuild acquisition	`ConsiderationPayableForResumebuildAcquisition`	-	USD	Annual
Principal of Paycheck Protection Program loans forgiven	`PrincipalOfPaycheckProtectionProgramLoansForgiven`	$184.91K	USD	Annual
Principal of Paycheck Protection Program loans forgiven	`PrincipalOfPaycheckProtectionProgramLoansForgiven`	$63.40K	USD	Annual
Additional purchase of membership in WorkSimpli issued in performance options	`PurchaseOfMembershipInterestInPerformanceOfOption`	$144.02K	USD	Annual
Additional purchase of membership in WorkSimpli issued in performance options	`PurchaseOfMembershipInterestInPerformanceOfOption`	-	USD	Annual
Warrants issued for debt instruments	`NonCashWarrantsIssuedForDebtInstruments`	$6.27M	USD	Annual
Warrants issued for debt instruments	`NonCashWarrantsIssuedForDebtInstruments`	-	USD	Annual
Right of use asset	`RightOfUseAsset`	$1.75M	USD	Annual
Right of use asset	`RightOfUseAsset`	$89.59K	USD	Annual
Right of use lease liability	`CapitalLeaseObligationsIncurred`	$1.79M	USD	Annual
Right of use lease liability	`CapitalLeaseObligationsIncurred`	$94.17K	USD	Annual

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Balance,	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$21.71M	USD	Point-in-time
Balance,	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.48M	USD	Point-in-time
Balance,	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-11.87M	USD	Point-in-time
Stock compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$12.07M	USD	Annual
Stock compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$13.73M	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$670.75K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$90.40K	USD	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	90,400.00	shares	Annual
Exercise of stock options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	375,000.00	shares	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$480.61K	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$38.50K	USD	Annual
Cashless exercise of stock options	`StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions`	-	USD	Annual
Cashless exercise of stock options	`StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions`	-	USD	Annual
Warrants issued for debt instruments	`WarrantsIssuedForDebtInstruments`	$6.27M	USD	Annual
Sale of common stock in private placement, net	`SaleOfCommonStockInPrivatePlacementNet`	$13.50M	USD	Annual
Sale of common stock under ATM, net	`SaleOfCommonStockUnderAtmNet`	$493.48K	USD	Annual
Sale of Series A Preferred Stock	`SaleOfSeriesPreferredStock`	$33.51M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueSaleOfCommonStock`	$21.84M	USD	Annual
Series A Preferred Stock Dividends	`SeriesAPreferredStockDividend`	$-871.48K	USD	Annual
Series A Preferred Stock Dividends	`SeriesAPreferredStockDividend`	$-3.11M	USD	Annual
Distribution to non-controlling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$144.00K	USD	Annual
Distribution to non-controlling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$144.00K	USD	Annual
Purchase of additional membership interest of WorkSimpli	`PurchaseOfAdditionalMembershipInterestOfWorksimpli`	$-444.02K	USD	Annual
Adjustment of non-controlling interest for additional investment	`AdjustmentOfNoncontrollingInterestForAdditionalInvestment`	$144.02K	USD	Annual
Net (loss) income	`ProfitLoss`	$-61.32M	USD	Annual
Net (loss) income	`ProfitLoss`	$-45.02M	USD	Annual
Stock issued for legal settlement	`StockIssuedDuringPeriodValueOther`	$816.00K	USD	Annual
Stock issued for legal settlement, shares	`StockIssuedDuringPeriodSharesOther`	400,000.00	shares	Annual
Adjustment of membership interest in WorkSimpli	`AdjustmentsToAdditionalPaidInCapitalOther`	$12.15K	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$21.71M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.48M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-11.87M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.